-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Rhythm Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q3 2024.
- Rhythm Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$344K, a 193% decline year-over-year.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)